Detection of mutations in hepatitis B virus enhancer 2/core promoter and X protein regions in patients with fatal hepatitis B virus infection
Arata Honda
First Department of Medicine, Chiba University School of Medicine, Chiba, Japan
Search for more papers by this authorCorresponding Author
Osamu Yokosuka
First Department of Medicine, Chiba University School of Medicine, Chiba, Japan
First Department of Medicine, Chiba University School of Medicine, 1-8-1 Inohana Chuo-ku, Chiba (260-8670), Japan===Search for more papers by this authorKazuyuki Suzuki
First Department of Internal Medicine, Iwate Medical University School of Medicine, Iwate, Japan
Search for more papers by this authorHiromitsu Saisho
First Department of Medicine, Chiba University School of Medicine, Chiba, Japan
Search for more papers by this authorArata Honda
First Department of Medicine, Chiba University School of Medicine, Chiba, Japan
Search for more papers by this authorCorresponding Author
Osamu Yokosuka
First Department of Medicine, Chiba University School of Medicine, Chiba, Japan
First Department of Medicine, Chiba University School of Medicine, 1-8-1 Inohana Chuo-ku, Chiba (260-8670), Japan===Search for more papers by this authorKazuyuki Suzuki
First Department of Internal Medicine, Iwate Medical University School of Medicine, Iwate, Japan
Search for more papers by this authorHiromitsu Saisho
First Department of Medicine, Chiba University School of Medicine, Chiba, Japan
Search for more papers by this authorAbstract
The enhancer 2/core promoter and the X protein regions located upstream of the precore and core regions in hepatitis B virus regulate expression of core/e antigen peptides. Mutations in the precore and core regions have been reported to be associated closely with the severity of type B hepatitis, and regions regulating expression of these peptides may also be involved in severe liver damage. Mutations were examined in regions that may be related to fatal liver diseases. Nucleotide sequences and deduced amino acid sequences from 20 patients with fatal type B hepatitis (12 with fulminant hepatitis and 8 with severe exacerbation) and 10 patients with self-limited acute hepatitis were analyzed. There were 50 nucleotide alterations in the enhancer 2/core promoter region of virus from 12 patients with fulminant hepatitis (average 4.1/case), 37 alterations in 8 patients with severe exacerbation (4.6/case), and 10 mutations in 10 cases of acute hepatitis (1.0/case). The numbers of amino acid mutations in X protein were 53 in 12 cases of fulminant hepatitis (4.4/case), 27 in 8 cases of severe exacerbation (3.3/case), and 9 in 10 cases of acute hepatitis (0.9/case). In fatal cases, approximately 50% of the nucleotide mutations were located within the region spanning nucleotides 1741–1777 (14.2% of the enhancer 2/core promoter region) and 30% of the amino acid mutations in X protein were located within the region containing codons 122–132 (7.1% of X protein). In addition to mutations in the precore and core regions, mutations in the enhancer 2/core promoter and the X protein regions may be associated with the pathogenesis of fatal B hepatitis infection. J. Med. Virol. 62:167–176, 2000. © 2000 Wiley-Liss, Inc.
REFERENCES
- Asahina Y, Enomoto N, Ogura Y, Sakuma I, Kurosaki M, Izumi N, Marumo F, Sato C. 1996. Complete nucleotide sequences of hepatitis B virus genomes associated with epidemic fulminant hepatitis. J Med Virol 48: 171–178.
10.1002/(SICI)1096-9071(199602)48:2<171::AID-JMV9>3.0.CO;2-6 CAS PubMed Web of Science® Google Scholar
- Aufiero B, Schneider RJ. 1990. The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J 9: 497–504.
- Arii M, Takada S, Koike K. 1992. Identification of three essential regions of hepatitis B virus X protein for trans-activation function. Oncogene 7: 397–403.
- Baumert TF, Rogers SA, Hasegawa K, Liang TJ. 1996. Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 98: 2268–2276.
- Baumert TF, Marrone A, Vergalla J, Liang TJ. 1998. Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression. J Virol 72: 6785–6795.
- Bichko V, Dreilina D, Pumpen P, Gren E. 1985. Subtype ayw variant of hepatitis B virus. FEBS Lett 185: 208–212.
- Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MLJ, Makris A, Thomas HC. 1989. Mutations preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 2: 588–590.
- Ehata T, Omata M, Chuang WL, Yokosuka O, Hosoda K, Ohto M. 1993. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest 91: 1206–1213.
- Fujiyama A, Miyanohara A, Nozaki C, Yoneyama T, Ohtomo N, Matsubara K. 1983. Cloning and structural analyses of hepatitis B virus DNAs, subtype adr. Nucleic Acids Res 11: 4601–4610.
- Galibert F, Mandart E, Fitossi F, Tiollais P, Charnay P. 1979. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281: 646–650.
- Gunther S, Piwon N, Iwanska A, Schilling R, Meisel H, Will H. 1996. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J Virol 70: 8318–8331.
- Gunther S, Piwon N, Will H. 1998. Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) → T, A(1762) → T and G(1764) → A mutations in the core promoter. J Gen Virol 79: 375–380.
- Hasegawa K, Huang J, Rogers SA, Blum HE, Liang TJ. 1994. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol 68; 1651–1659.
- Hoofnagle JH. 1983. Chronic type B hepatitis. Gastroenterology 84: 422–424.
- Honda A, Yokosuka O, Ehata T, Tagawa M, Imazeki F, Saisho H. 1999. Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: comparison with mutations in precore and core regions in relation to clinical status. J Med Virol 57: 337–344.
10.1002/(SICI)1096-9071(199904)57:4<337::AID-JMV2>3.0.CO;2-L CAS PubMed Web of Science® Google Scholar
- Hu KQ, Vierling JM, Siddiqui A. 1990. Trans-activation of HLA-DR gene by hepatitis B virus X gene product. Proc Natl Acad Sci USA 87: 7140–7144.
- Jeenah M, Kessling A, Miller N, Humphries S. 1990. G to A substitution in the promoter region of the apolipoprotein Al gene is associated with elevated serum apolipoprotein Al and high density lipoprotein choresterol concentrations. Mol Biol Med 7: 233–241.
- Kobayashi M, Koike K. 1984. Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization. Gene 30: 227–232.
- Koike K, Shirakata Y, Yaginuma K, Arii M, Tanaka S. 1989. Oncogenic potential of hepatitis B virus. Mol Biol Med 6: 151–160.
- Kosaka Y, Takase K, Kojima M, Shimizu M, Inoue K, Yoshiba M, Tanaka S, Akahane Y, Okamoto H, Tsuda F, Miyakawa Y, Mayumi M. 1991. Fulminant hepatitis B: induction by hepatitis virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology 100: 1087–1094.
- Laskus T, Persing DH, Nowicki MJ, Mosley JW, Rakela J. 1993. Nucleotide sequence analysis of precore region in patients with fulminant hepatitis B in the United States. Gastroenterology 105: 1173–1178.
- Laskus T, Rakela J, Nowicki MJ, Persing DH. 1995. Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B. Gastroenterology 109: 1618–1623.
- Li J, Buckwold VE, Hon MW, Ou JH. 1999. Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. J Virol 73: 1239–1244.
- Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E. 1991. A hepatitis B mutation associated with an epidemic of fulminant hepatitis. N Engl J Med 324: 1705–1709.
- Mahe Y, Makaida N, Kuno K, Akiyama M, Ikeda N, Matsushima K, Murakami S. 1991. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis elements. J Biol Chem 266: 13759–13763.
- Milich DR, Jones J, Hughes J, Maruyama T. 1993. Roles of T-cell tolerance in the persistence of hepatitis B virus infection. J Immunother 1993 14: 226–233.
- Ogata N, Miller RH, Ishak KG, Purcell RH. 1993. The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. Virology 194: 263–276.
- Okamoto H, Imai M, Shimozaki M, Hoshi Y, Iizuka H, Gotanda B, Tsuda F, Miyakawa Y, Mayumi M. 1986. Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: comparison with genomes of the other three subtypes. J Gen Virol 67: 2305–2314.
- Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M. 1988. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69: 2575–2583.
- Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. 1991. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 324: 1688–1704.
- Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K. 1983. The complete nucleotide sequence of the cloned hepatitis B virus DNA: subtype adr and adw. Nucleic Acid Res 11: 1747–1757.
- Phares W, Herr W. 1991. Functional similarities between immunodeficiency virus type 1 and simian virus 40kB proto-enhancers. J Virol 65: 2200–2210.
- Ritter SE, Whitten TM, Quets AT, Schloemer RH. 1991. An internal domain of hepatitis B virus X antigen is necessary for transactivating activity. Virology 182: 841–845.
- Roh H, Kim K, Hyun SW, Kim YS. 1989. The nucleotide sequence and reading frames of a mutant hepatitis B virus adr. Nucleic Acid Res 17: 2124.
- Runkel L, Fischer M, Schaller H. 1993. Two-codon mutations of the HBx define two separate regions necessary for its trans-activation function. Virology 197: 529–536.
- Sato S, Suzuki K, Akahane Y, Akamatsu K, Akiyama K, Yunomura K, Tsuda F, Tanaka T, Okamoto H, Miyakawa Y, Mayumi M. 1995. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 122: 241–248.
- Siddiqui A, Gaynor R, Srinivasan A, Mapoles J, Farr RW. 1989. Trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein. Virology 169: 479–484.
- Spandau DF, Lee CH. 1988. Transactivation of viral enhancers by the hepatitis B virus X protein. J Virol 62: 427–434.
- Steffy KR, Weir JP. 1991. Mutational analysis of two herpes simplex virus type 1 later promoters. J Virol 65: 6454–6460.
- Sterneck M, Gunther S, Santantonio T, Fischer L, Broelsch CE, Greten H, Will H. 1996. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation. Hepatology 24: 300–306.
- Sterneck M, Kalinina T, Gunther S, Fischer L, Santantonio T, Greten H, Will H. 1998A. Functional analysis of HBV genomes from patients with fulminant hepatitis. Hepatology 28: 1390–1397.
- Sterneck M, Kalinina T, Otto S, Gunther S, Fischer L, Burdelski M, Greten H, Broelsch CE, Will H. 1998B. Neonatal fulminant hepatitis B: structural and functional analysis of complete hepatitis B virus genomes from mother and infant. J Infect Dis 177: 1378–1381.
- Tada M, Omata M, Ohto M. 1990. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Cancer Res 50: 1121–1124.
- Tay N, Chan SH, Ren EC. 1992. Identification and cloning of a novel heterogeneous nuclear ribonucleoprotein C-like protein that functions as a transcriptional activator of the hepatitis B virus enhancer II. J Virol 66: 6841–6848.
- Twu JS, Schloemer RH. 1987. Transcriptional trans-activating function of hepatitis B virus. J Virol 61: 3448–3453.
- Twu JS, Rosen CA, Haseltine WA, Robinson WS. 1989. Identification of a region within the HIV LTR is essential for transactivation by HBV gene X. J Virol 63: 2857–2860.
- Yokosuka O, Omata M, Hosoda K, Tada M, Ehata T, Ohto M. 1991. Detection and direct sequencing of hepatitis B virus genome by DNA amplification method. Gastroenterology 100: 175–181.
- Yuh CH, Chang YL, Ting LP. 1992. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J Virol 66: 4073–4084.
- Zahm P, Hofschneider PH, Koshy R. 1988. The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene 3: 169–177.
- Zhang P, Raney AK, McLachlan A. 1993. Characterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter. J Virol 67: 1472–1481.